CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial

Alejandra Garcia-Botella, Patricia Sáez-Carlin, Ramiro Méndez, Maria Paz Martin, Luis Ortega, Jose Vicente Méndez, Beatriz García-Paredes, L Diez-Valladares, Antonio Jose Torres

Open source

DOI
10.1016/j.suronc.2019.10.005
Published
2020-06
Container
Surgical Oncology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.suronc.2019.10.005,
  title = {CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial},
  author = {Alejandra Garcia-Botella and Patricia Sáez-Carlin and Ramiro Méndez and Maria Paz Martin and Luis Ortega and Jose Vicente Méndez and Beatriz García-Paredes and L Diez-Valladares and Antonio Jose Torres},
  year = {2020},
  journal = {Surgical Oncology},
  doi = {10.1016/j.suronc.2019.10.005},
  url = {https://doi.org/10.1016/j.suronc.2019.10.005}
}

RIS

TY  - JOUR
TI  - CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial
AU  - Alejandra Garcia-Botella
AU  - Patricia Sáez-Carlin
AU  - Ramiro Méndez
AU  - Maria Paz Martin
AU  - Luis Ortega
AU  - Jose Vicente Méndez
AU  - Beatriz García-Paredes
AU  - L Diez-Valladares
AU  - Antonio Jose Torres
PY  - 2020
JO  - Surgical Oncology
DO  - 10.1016/j.suronc.2019.10.005
UR  - https://doi.org/10.1016/j.suronc.2019.10.005
ER  - 

APA

Garcia-Botella, A., Sáez-Carlin, P., Méndez, R., Martin, M. P., Ortega, L., Méndez, J. V., García-Paredes, B., Diez-Valladares, L., & Torres, A. J. (2020). CD133 + cell infusion in patients with colorectal liver metastases going to be submitted to a major liver resection (CELLCOL): A randomized open label clinical trial. Surgical Oncology. https://doi.org/10.1016/j.suronc.2019.10.005

Source records